Biotech Ingredients Market, By Type, By Expression System, By Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

The market for Biotech Ingredients was projected to reach USD 2,151.5 million in 2023 and expand at a CAGR of 8.00% between 2024 - 2032.

The majority of biotech ingredients are natural and include oleoresins, essential oils, and other plant extracts. Common methods for obtaining these compounds include carbon dioxide extraction, solvent extraction, steam distillation, and cold pressing or compression. Biotech ingredients, like biopharmaceuticals, include complex proteins, such antibodies, nucleic acids, or antisense oligonucleotides, which are given by methods different from direct extraction from natural, non-engineered living forms. Due to reasons including consumers' growing preference for natural and organic products, the market for biotech ingredients has grown significantly. Additionally, this market is being driven by the growing usage of biotech components in various end-use industries, including medicines, cosmetics, and food & beverage. In addition, technological developments pertaining to monoclonal antibodies and next-generation antibody therapeutics, including antibody-drug conjugates by major companies, are some other aspects anticipated to further influence the biotech ingredients market.

Biotech Ingredients Market- Market Dynamics

Rising Need for Generic Medications

It is anticipated that the market for biotech ingredients will continue to expand due to the growing need for generic medications. A generic medication is intended to have the same qualities as a previously authorized medication. General medicine uses biotech substances because they are the main source of less expensive, more effective ways to produce a variety of active ingredients that are almost comparable to the original product and are usually subject to a more stringent set of regulations. For instance, in September 2022, the U.S. Generic and Biosimilar Medicines Savings Report, published by the Biosimilars Council, a division of the Association for Accessible Medicines (AAM), a US-based association of generic medicine manufacturers and distributors, revealed that 91% of the 6.4 billion prescriptions were written for patients in the US in 2021 for generic or biosimilar medications. With generic medications accounting for 3% of all healthcare spending, patients, consumers, employers, and taxpayers saved $373 billion by using these less expensive medications. Thus, the market for biotech ingredients is expanding due to the increased demand for generic medications.

Biotech Ingredients Market- Key Insights

According to our research analyst's analysis, the global market is projected to expand at a CAGR of approximately 8.00% during the forecast period of 2024-2032.

The active pharmaceutical ingredients category was predicted to hold the largest market share in 2023 based on type.

The microbial expression systems category was predicted to hold the largest market share in 2023 based on expression systems.

North America held the largest revenue share by region in 2023.

Biotech Ingredients Market- Segmentation Analysis:

The Global Biotech Ingredients Market is segmented into Type, Expression System, Application, and Region.

The global market for biotech ingredients is divided into two segments based on type: biosimilars and active pharmaceutical ingredients. In 2023, the market's largest contributor is the active pharmaceutical ingredients category. Active pharmaceutical ingredients (APIs) are the chemicals or a mixture of substances utilized in final or finished products. They are intended for use in pharmacology studies to investigate the effects of drugs on living organisms when they are used to treat different diseases. When researching causes and consequences that are directly related to different diagnoses, cures, preventive, therapy, and mitigation aims, APIs are used. In most cases, a formulation uses the most thermodynamically stable crystalline form of API. The quality of APIs strongly impacts the efficacy and safety of pharmaceuticals.

Based on application, the market is segmented into Vaccines, Monoclonal Antibodies, Cytokines, Hormones and Growth Factors, Fusion Proteins, Blood Factors, and Therapeutic Enzymes. Due to its high specificity, low toxicity, and capacity to target particular disease markers, monoclonal antibodies are expected to dominate the global market for biotech ingredients. Additionally, the growing incidence of chronic illnesses and the demand for individualized treatment options will propel market expansion. Synthetic proteins known as monoclonal antibodies (mAbs) replicate the immune system's ability to fight off intruders by targeting particular cells or proteins. These biotech components have grown significantly in the pharmaceutical industry because of their therapeutic applications in the treatment of many illnesses, including cancer, autoimmune diseases, and infectious diseases.

Biotech Ingredients Market- Geographical Insights

The Biotech Ingredients market is widely distributed geographically in North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further separated based on the countries that provide business.

The market for biotech ingredients is dominated by North America, mostly because of the region's strong pharmaceutical and food companies as well as its substantial investments in biotechnology R&D. The market's expansion is being aided by the region's established healthcare system and advantageous regulatory environment. Due to the increasing demand for biotech ingredients in food and drink, cosmetics, and pharmaceuticals, the US is a significant contributor to the market. With the help of growing biotechnology investments and growing consumer awareness of sustainable products, Canada is also experiencing rapid growth.

Additionally, with the help of a large number of pharmaceutical and cosmetic firms as well as rising consumer demand for sustainable products, Europe also commands a sizable portion of the market for biotech ingredients. The market is mostly driven by Germany, France, and the United Kingdom, all of which have made large expenditures in biotechnology R&D. The use of biotech substances is being fueled by the region's strict regulations and emphasis on environmental sustainability. Furthermore, the growing popularity of natural & organic products is driving the European biotech ingredients market's expansion.

Biotech Ingredients Market- Competitive Landscape:

The market for biotech ingredients is characterized by a dynamic competitive environment with many well-established companies and newcomers vying for market share in the expanding demand for cutting-edge biotechnology solutions across a range of industries. Important companies such as AbbVie Inc., Pfizer Inc., Boehringer Ingelheim International GmbH, Lilly, GSK Plc, Novartis AG, and others always work on R&D projects to expand their product lines, emphasizing technological improvements, sustainable business practices, and regulatory compliance. In order to meet changing customer demands and maintain a competitive edge in the market, industry players are attempting to broaden their worldwide reach and provide a variety of biotech ingredients through strategic alliances, mergers, and acquisitions.

Recent Developments:

May 2023: The renowned biotech company Willow Biosciences Inc., which aims to revolutionize the industrial production of sustainable and pure functional components, has inked a Master Services Agreement with a cutting-edge biotech company that focuses on age-related illnesses. In this partnership, it will develop precise fermentation processes for a particular class of molecules created as active pharmaceutical ingredients (APIs) and nutritional supplements for health and wellness.

February 2023: CETO3 is an omega-3 and cetoleic acid that Grntvedt Biotech introduced. It has been investigated if cetoleic acid, sometimes referred to as "omega 11," can change alpha-lipoic acid (ALA), a plant-based omega-3 fatty acid, into eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in liver cells. It's a chemical from Norwegian herring that's being used for skin and heart health.

February 2022: For $226 million, the Irish taste and nutrition giant Kerry Group plc purchased c-LEcta. Kerry hopes to enhance its innovation efforts in fermentation, enzyme engineering, and biotechnological development with this acquisition. Kerry also intends to make investments in the development of innovative sustainable technologies that will propel the future growth of sustainable food and health systems. c-LEcta is a biotechnology innovation company based in Germany that specializes in producing high-value targeted biomolecules and ingredients through extremely accurate fermentation, optimized bio-processing, and bio-transformation.

SCOPE OF THE REPORT

The scope of this report covers the Biotech Ingredients market by its major segments, which include as follows:

GLOBAL BIOTECH INGREDIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie Inc. (U.S.)
Pfizer Inc. (U.S.)
Boehringer Ingelheim International GmbH. (Germany)
Lilly (U.S.)
GSK Plc (U.K.)
Novartis AG (Switzerland)
Bristol-Myers Squibb Company (U.S.)
Merck & Co (U.S.).
Sanofi (France)
bioMerieux (France)
Cepheid Inc. (U.S.)
AstraZeneca (U.K.)
Mylan N.V (U.S.)
BD (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Bruker (U.S.)
Others

GLOBAL BIOTECH INGREDIENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Biosimilars
Active Pharmaceutical Ingredients

GLOBAL BIOTECH INGREDIENTS MARKET, BY EXPRESSION SYSTEM- MARKET ANALYSIS, 2019 - 2032

Plant Expression Systems
Mammalian Expression Systems
Yeast Expression Systems
Microbial Expression Systems
Insect Expression Systems

GLOBAL BIOTECH INGREDIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Vaccines
Monoclonal Antibodies
Cytokines
Hormones and Growth Factors
Fusion Proteins
Blood Factors
Therapeutic Enzymes

GLOBAL BIOTECH INGREDIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4267

1. Biotech Ingredients Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Biotech Ingredients Market Snippet by Type
- 2.1.2. Biotech Ingredients Market Snippet by Expression System
- 2.1.3. Biotech Ingredients Market Snippet by Application
- 2.1.4. Biotech Ingredients Market Snippet by Country
- 2.1.5. Biotech Ingredients Market Snippet by Region
2.2. Competitive Insights

3. Biotech Ingredients Key Market Trends

3.1. Biotech Ingredients Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Biotech Ingredients Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Biotech Ingredients Market Opportunities
3.4. Biotech Ingredients Market Future Trends

4. Biotech Ingredients Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Biotech Ingredients Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Biotech Ingredients Market Landscape

6.1. Biotech Ingredients Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Biotech Ingredients Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 7.1.2. Biosimilars
- 7.1.3. Active Pharmaceutical Ingredients

8. Biotech Ingredients Market - By Expression System

8.1. Overview
- 8.1.1. Segment Share Analysis, By Expression System, 2023 & 2032 (%)
- 8.1.2. Plant Expression Systems
- 8.1.3. Mammalian Expression Systems
- 8.1.4. Yeast Expression Systems
- 8.1.5. Microbial Expression Systems
- 8.1.6. Insect Expression Systems

9. Biotech Ingredients Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Vaccines
- 9.1.3. Monoclonal Antibodies
- 9.1.4. Cytokines
- 9.1.5. Hormones and Growth Factors
- 9.1.6. Fusion Proteins
- 9.1.7. Blood Factors
- 9.1.8. Therapeutic Enzymes

10. Biotech Ingredients Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Biotech Ingredients Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Biotech Ingredients Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Biotech Ingredients Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Biotech Ingredients Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Biotech Ingredients Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Expression System, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biotech Ingredients Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. AbbVie Inc. (U.S.)
- 11.2.2. Pfizer Inc. (U.S.)
- 11.2.3. Boehringer Ingelheim International GmbH. (Germany)
- 11.2.4. Lilly (U.S.)
- 11.2.5. GSK Plc (U.K.)
- 11.2.6. Novartis AG (Switzerland)
- 11.2.7. Bristol-Myers Squibb Company (U.S.)
- 11.2.8. Merck & Co (U.S.).
- 11.2.9. Sanofi (France)
- 11.2.10. bioMerieux (France)
- 11.2.11. Cepheid Inc. (U.S.)
- 11.2.12. AstraZeneca (U.K.)
- 11.2.13. Mylan N.V (U.S.)
- 11.2.14. BD (U.S.)
- 11.2.15. Teva Pharmaceutical Industries Ltd. (Israel)
- 11.2.16. Bruker (U.S.)
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us